Edition:
United States

Insider Trading: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,692JPY
2:00am EDT
Change (% chg)

¥24 (+1.44%)
Prev Close
¥1,668
Open
¥1,667
Day's High
¥1,695
Day's Low
¥1,666
Volume
11,805,400
Avg. Vol
7,976,963
52-wk High
¥2,009
52-wk Low
¥1,358

All Insider Trades

Institutional Holders

% Shares Owned: 48.35%
# of Holders: 436
Total Shares Held: 1,041,278,155
3 Mo. Net Change: -14,184,658
# New Positions: 8
# Closed Positions: 7
# Increased Positions: 72
# Reduced Positions: 71
# Net Buyers: 1

Officers & Directors

Name Age Since Current Position

Yoshihiko Hatanaka

59 2016 President, Chief Executive Officer, Chairman of the Board of Directors, Representative Director

Yoshiro Miyokawa

62 2013 Vice President, Representative Director

Yukihiko Sato

2015 Senior Executive Officer, Chief Director of Sales

Yasumasa Masuda

Senior Executive Officer

Mitsunori Matsuda

2015 Senior Executive Officer, Chief Director of Technology

Makoto Takeuchi

2015 Senior Executive Officer, Director of External Affairs

Wataru Uchida

2015 Senior Executive Officer, Chief Director of Research

Kenji Yasukawa

2014 Senior Executive Officer

Chihiro Yokota

2015 Senior Executive Officer, Chief Director of Development

Masao Yoshida

2014 Senior Executive Officer, Manager of America Business

Atsushi Kamide

Executive Officer, Director of Product Marketing in Main Sales Unit

Fumiaki Sakurai

Executive Officer, Director of Human Resources

Kiyotaka Hayashi

2014 Executive Officer, Manager of Osaka Office in Main Sales Unit

Takahisa Iizuka

Executive Officer, Director of Sales Promotion in Main Sales Unit

Akihiko Iwai

2014 Executive Officer, Director of Research Portfolio & Science in Main Research Unit

Masatoshi Kuroda

2014 Executive Officer, Chief Director of Asia & Oceania Business

Yukio Matsui

Executive Officer, Manager of Global Marketing Strategic Function

Eisuke Nozawa

Executive Officer, Director of Pharmaceutical Affairs

Kazunori Okimura

Executive Officer, Director of Legal Affairs & Compliance

Katzumi Ozawa

Executive Officer, Manager of Tokyo Office in Main Sales Unit

Kazuhiro Sako

Executive Officer, President of Subsidiary

Taiji Sawamoto

Executive Officer, Director of Clinical Pharmacology in Main Development Unit

Chikashi Takeda

2014 Executive Officer, Director of Business Planning

Nobuaki Tanaka

Executive Officer, Manager of Chiba Office in Main Sales Unit

Shoji Yokota

Executive Officer, Director of Technology Promotion in Main Technology Unit

Toru Yoshimitsu

Executive Officer, Director of Product Strategy

Yoshiharu Aizawa

69 2015 Independent Director

Yutaka Kase

68 2013 Independent Director

Etsuko Okajima

49 2014 Independent Director

Hironobu Yasuda

65 2013 Independent Director

Yuichi Murakami

Director of Accounting